Globus Medical, Inc.
Globus Medical, Inc. (GMED) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · GMED · as of Sep 30, 2025
Ownership Breakdown
502
Institutional Holders
▲ 11 vs Q2
$6.65B
Total Inst. Value
▼ $76.98M vs Q2
134.86M
Shares Outstanding
freeFloat 99.29%
115.93M
13F Shares Held
▲ 1.84M vs Q2
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
GMED largest shareholders · institutional ownership
Q3 2025 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
VANGUARD GROUP INC surgical & medical instruments & apparatus | 10.61M | 7.84% | 7.84% | $607.39B | Nov 7, 2025 | ▼ 103.1K |
BLACKROCK, INC. surgical & medical instruments & apparatus | 10.53M | 7.79% | 7.79% | $603.24B | Nov 12, 2025 | ▼ 230.2K |
JANUS HENDERSON GROUP PLC surgical & medical instruments & apparatus | 7.55M | 5.59% | 5.59% | $432.54B | Nov 14, 2025 | ▼ 654.3K |
JPMORGAN CHASE & CO surgical & medical instruments & apparatus | 3.68M | 2.72% | 2.72% | $210.87B | Nov 26, 2025 | ▲ 341.2K |
SCULPTOR CAPITAL LP surgical & medical instruments & apparatus | 3.50M | 2.59% | 2.59% | $200.44B | Nov 14, 2025 | ▲ 739.3K |
STATE STREET CORP surgical & medical instruments & apparatus | 3.46M | 2.56% | 2.56% | $198.25B | Nov 14, 2025 | ▼ 11.8K |
BURGUNDY ASSET MANAGEMENT LTD. surgical & medical instruments & apparatus | 3.46M | 2.56% | 2.56% | $212.05B | Nov 12, 2025 | ▼ 20.5K |
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC surgical & medical instruments & apparatus | 2.82M | 2.09% | 2.09% | $161.45B | Nov 12, 2025 | ▲ 414.1K |
MADISON AVENUE PARTNERS, LP surgical & medical instruments & apparatus | 2.55M | 1.88% | 1.88% | $145.93B | Nov 14, 2025 | ▲ 836.0K |
GENEVA CAPITAL MANAGEMENT LLC surgical & medical instruments & apparatus | 2.08M | 1.54% | 1.54% | $119.35B | Nov 13, 2025 | ▲ 1.2K |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q3 2025 vs prior quarter
Q3 2025
30
Increased
+9.74M shares3
New Positions
first time holders16
Decreased
−3.72M shares0
Sold Out
fully exitedNet shares change (top 50)
+6.02M
+9.74M / −3.72M
Net new holders
+17
3 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
GMED insider trading · insider activity
Source: SEC Form 4
Insiders have been primarily selling shares recently. Selling may be driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment.
16
Buy transactions
7
Sell transactions
2.29
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Huller Kelly EVP, GC, Corporate Secretary | Feb 25, 2026 | Sale | 20,000 | $94.50 | $1.89M | 0 | Form 4 ↗ |
Huller Kelly EVP, GC, Corporate Secretary | Feb 12, 2026 | Sale | 10,000 | $87.67 | $876.7K | 0 | Form 4 ↗ |
Norwalk Leslie V director | Jan 21, 2026 | Award | 15,000 | $94.15 | $1.41M | 15.0K | Form 4 ↗ |
Pfeil Keith W President, CEO | Jan 21, 2026 | Award | 100,000 | $94.15 | $9.41M | 100.0K | Form 4 ↗ |
Kline Kyle Senior Vice President, CFO | Jan 21, 2026 | Award | 30,000 | $94.15 | $2.82M | 30.0K | Form 4 ↗ |
Paul David C Executive Chairman | Jan 21, 2026 | Award | 100,000 | $94.15 | $9.41M | 100.0K | Form 4 ↗ |
Douglas Robert Andrew director | Jan 21, 2026 | Award | 15,000 | $94.15 | $1.41M | 15.0K | Form 4 ↗ |
Lemaitre Dan director | Jan 21, 2026 | Award | 15,000 | $94.15 | $1.41M | 15.0K | Form 4 ↗ |
RHOADS ANN D director | Jan 21, 2026 | Award | 15,000 | $94.15 | $1.41M | 15.0K | Form 4 ↗ |
TOBIN JAMES R director | Jan 21, 2026 | Award | 15,000 | $94.15 | $1.41M | 15.0K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Globus Medical, Inc. (GMED) is primarily owned by institutional investors, who hold approximately 86.0% of total shares outstanding. Company insiders own approximately 0.71%, while retail and public investors account for the remaining 13.32%.
The largest institutional shareholder of Globus Medical, Inc. is VANGUARD GROUP INC, holding approximately 10.61 million shares — equal to 7.84% of outstanding shares — as of September 30, 2025.
A total of 502 institutional investors currently hold GMED stock, with a combined institutional value of approximately $6.65 billion as of the most recent 13F filing period.
Frequently asked questions
GMED ownershipGlobus Medical, Inc. (GMED) is primarily owned by institutional investors, who hold approximately 86.0% of shares. The largest shareholder is VANGUARD GROUP INC with a 7.84% stake. Company insiders hold 0.71%. Data sourced from SEC Form 13F as of September 30, 2025.